Affidea invests in b-rayZ: the advisors
Affidea completed its investment in b-rayZ as part of a new financing round. In connection with the operation, Kellerhals Carrard advised b-rayZ, while Niederer Kraft Frey supported Affidea.
The context
Headquartered in Schlieren, Switzerland, medtech company b-rayZ specialises in AI-powered breast imaging solutions. Affidea Group is a European provider of community-based polyclinics, specialist services and advanced diagnostics.
Pursuant to the transaction, Affidea has joined b-rayZ’s series A extension financing round as a strategic investor. The partnership further recognizes b-rayZ as Affidea’s preferred AI partner for breast imaging.
The Kellerhals Carrard team
Partner Umberto Milano (VC/M&A, pictured) led the Kellerhals Carrard team on the matter, working alongside partner Kerim Tbaishat (tax), senior associate Gaspare Loderer (data protection), associate Vera Vallone (IP), associate Jascha Mattmann (VC/M&A) and paralegal Lisa Schmid.
The NKF team
Corporate/M&A partner Philippe Weber led the NKF team on the operation, alogside corporate/M&A senior associate Samuel Hochstrasser and healthcare/regulatory partner Janine Reudt-Demont. Moreover, associate Pascal Hodel, junior associate Philipp Theiler (both corporate/M&A) and senior associate Sven Kälin (tax) further contributed to the team effort.
